Deadline: 21 October 2024
The Canadian Asthma, Allergy and Immunology Foundation is seeking applications for the Upper Airway Allergic Disease Research Grant Program to improve the lives of Canadians living with allergy, asthma and immunologic diseases.
Objective
- The objective of the CAAIF Research Grant in Upper Airway Allergic Disease supported by AstraZeneca Canada is to fund a research grant focused on the area of upper airway allergic disease.
Funding Information
- The maximum value of the award is $40,000.
Eligibility Criteria
- The award must be held at a Canadian university or research institute defined as an eligible institution by CIHR
- Preference will be given to investigators who have not received CAAIF award within the past two years
- Application must align with CAAIF’s mission statement
- Investigator-initiated studies of commercial pharmaceutical products eligible for industry sponsorship will not be considered except under special circumstances
Selection Criteria
- Specific impact and relevance of project to the understanding of the mechanisms and management of upper airway allergic disease (including but not limited to its development, persistence, desensitization, remission, diagnosis, clinical manifestation)
- Scientific strengths of the proposed methodology
- Demonstrated ability of applicant/collaborators to realistically achieve proposed project objectives
- Appropriateness of budget and timeline for the work proposed.
For more information, visit CAAIF.
